The Minister of Public Health (Minsanté), Manaouda Malachie, in a letter dated 6 April 2020, asked the Minister of Scientific Research and Innovation (Minresi), Madeleine Tchuinté, “to kindly launch, as of today, the production” of chloroquine.
The health minister notes that “the care protocol set up by clinicians, as part of the treatment of Covid-19 positive patients, is built around chloroquine.” However, says Manaouda Malachie, “this product has been withdrawn from our market for several years. As a result, treatment units are now out of supply.”
“We already have the equipment and as I speak to you, we have ordered the raw material from China and Indonesia. As soon as this raw material is here, we will make hydroxychloroquine tablets, which is the combination of chloroquine and Azithromicine,” said Prof. Jean-Louis Essame Oyono, the Director-General of the Institute of Medical Research and Studies of Medicinal Plants (IMPM). The IMPM can produce up to 6,000 chloroquine tablets per minute, according to the Minister of Scientific Research and Innovation.